-
GRE Combination Inhibits Melanogenesis via CREB/MITF
2026-09-30
The reference study shows that glabridin, resveratrol, and ellagic acid form a high-performing combination for suppressing melanin production, oxidative stress, and inflammatory signaling in cell-based assays. Its mechanistic contribution is the linkage of reduced melanogenesis with inhibition of CREB phosphorylation and MITF-associated gene and protein expression, while also providing a practical multi-endpoint framework for pigmentation regulation research.
-
REV1–DHX36 Control of G-Quadruplex Replication
2026-09-29
The reference study identifies a direct REV1–DHX36 partnership that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tier model explains how REV1 deficiency increases G4-associated replication stress, mutagenesis, and ATM/ATR signaling, while providing a mechanistic framework for genome-integrity and cancer research.
-
Dabigatran: A Metabolite-Aware Assay Strategy
2026-09-29
Dabigatran is more than a potent thrombin blocker: its active acylglucuronide metabolite can change how anticoagulant assays should be designed and interpreted. This guide translates comparative evidence into a metabolite-aware workflow for thrombin inhibition assays and coagulation function tests.
-
5X Protein Loading Buffer (Reducing): Practical Guide
2026-09-28
5X Protein Loading Buffer (Reducing) prepares protein samples for denaturing, reducing SDS-PAGE, helping standardize sample loading and molecular-weight separation. Use it when disulfide bonds should be reduced; do not use it for native analysis or experiments that require non-reducing disulfide patterns.
-
HotStart™ 2X Green qPCR Master Mix for Cell Assays
2026-09-27
A scenario-led guide to using HotStart™ 2X Green qPCR Master Mix (SKU K1070) alongside cell viability, proliferation, and cytotoxicity experiments. Learn where SYBR Green qPCR can clarify gene-expression changes, how to reduce avoidable amplification artifacts, and what to check when selecting a master mix.
-
Ziprasidone HCl: Mechanisms and Research Evidence
2026-09-26
Ziprasidone HCl is a second-generation antipsychotic compound with established dopamine and serotonin receptor pharmacology and reported GOT1-inhibitory activity in cancer research. This evidence review separates product-reported laboratory benchmarks from clinical findings and outlines the limits of translating them across research domains.
-
RAB31 Defines an ESCRT-Independent Exosome Route
2026-09-26
The study identifies RAB31 as a regulator of an exosome pathway that can form intraluminal vesicles independently of ESCRT machinery. RAB31 works with flotillin proteins to promote vesicle formation and recruits TBC1D2B to restrain RAB7-dependent lysosomal fusion, linking cargo sorting to the fate of multivesicular endosomes.
-
Pirfenidone in Pulmonary Fibrosis Research
2026-09-25
Use Pirfenidone as a pathway-aware antifibrotic benchmark to connect inflammatory, TGF-β, and matrix-remodeling readouts in pulmonary fibrosis models. Pair it with the recent worenine findings to distinguish shared fibrosis phenotypes from compound-specific signaling, without assuming a shared mechanism.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-09-25
Brasher and colleagues identify Munc18c as a regulator of syntaxin4-dependent invadopodium formation, linking SNARE-complex regulation to delivery of MT1-MMP and EGFR at the cell surface. Their perturbation experiments support a role for this trafficking pathway in extracellular-matrix invasion in vitro, while leaving its contribution to metastasis in vivo for future study.
-
Persistent rDNA Damage Triggers PML-Nucleolar Compartments
2026-09-24
Urbancokova, Hornofova and colleagues show that topological stress and RNA polymerase I inhibition can create persistent ribosomal DNA lesions associated with PML-nucleolar compartments (PNAs). Their experiments link these compartments to damaged rDNA and an incomplete homologous-recombination response, offering a framework for studying nucleolar genome maintenance and cellular senescence.
-
Amphotericin B: Membrane Assay Workflows
2026-09-24
Build reproducible fungal membrane assays with practical dose selection, vehicle controls, and troubleshooting for Amphotericin B. A classic protoplast study offers a useful membrane-assay design principle—but not direct evidence about this antifungal’s activity.
-
Perphenazine: Workflows for D2 and Immune Research
2026-09-23
Perphenazine combines dopamine D2 receptor antagonism with experimentally useful mitochondrial and macrophage phenotypes. This workflow-focused guide connects neuropharmacology, mitochondria-mediated cell death induction, and host-directed antibacterial assays while emphasizing controls, formulation, and interpretation limits.
-
How Kinase Inhibitors Promote p38α Dephosphorylation
2026-09-23
The reference preprint shows that some kinase inhibitors do more than occupy the p38α active site: they reshape its activation loop so WIP1 can dephosphorylate the kinase more efficiently. This dual-action mechanism links inhibitor binding to phosphatase accessibility and suggests a structure-guided route toward more potent and selective p38 pathway modulation.
-
Prednisolone for Glucocorticoid Signaling Research
2026-09-22
Prednisolone is a practical synthetic glucocorticoid for dissecting receptor-driven inflammation, immune regulation, and cellular response to corticosteroids. This guide separates those experiments from the ERAD-engaging chimera technology used for transmembrane protein degradation, helping researchers choose the right compound, controls, and readouts.
-
7-AAD Cell Viability Assay Kit for CAR-T
2026-09-21
The 7-AAD Cell Viability Assay Kit provides a red-fluorescent membrane-integrity readout for necrotic and late apoptotic cells. This 7-amino actinomycin D assay supports flow cytometry, fluorescence microscopy, and multiplex viability workflows in CD38 CAR-T research.